Tuberculosis screening for patients on biologic Medications: A Single-Center experience and Society guideline Review, Monroe County, New York, 2018-2021.

ABSTRACT:

Rationale

Biologic medications for immune-mediated inflammatory diseases may increase the risk of tuberculosis (TB) reactivation, but data on screening for TB in low TB prevalence areas are limited.

Objective

To assess the real-world practice patterns of TB screening among prescribers of biologic medications.

Methods

We conducted a retrospective observational study at a single, university-based healthcare facility in a low TB prevalence area. We enrolled adult patients prescribed a biologic medication between October 2018 and December 2021, and collected data on demographics, biologic medications and TB test results. For patients with positive TB tests, further data including prescriber specialty and response to positive tests were obtained. We reviewed pertinent majo

SUBMITTER: Maeda T 

PROVIDER: S-EPMC11254483 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature